Literatur
- 1
The Diabetic Retinopathy Study Research Group .
Indications for photocoagulation treatment of diabetic retinopathy.
Int Ophthalmol Clin.
1987;
27
239-253
- 2
The Central Vein Occlusion Study Group .
Natural history and clinical management of central retinal vein occlusion.
Arch Ophthalmol.
1997;
115
486-491
- 3
Macugen Retinopathy Diabetic Study Group .
Changes in retinal neovascularisation after pegaptanib (macugen) therapy in diabetic
individuals.
Ophthalmology.
2006;
113
23-28
- 4 Agostini H J, Funk J.
Neovaskuläres Glaukom. Schlote TRJ Sekundärglaukome. Stuttgart; Schattauer 2004: 237-248
- 5
Aiello L P, Avery R L, Arrigg P G et al.
Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy
and other retinal disorders.
N Engl J Med.
1994;
331
1480-1487
- 6
Arevalo J F, Wu L, Sanchez J G et al.
Intravitreal bevacizumab (Avastin) for proliferative diabetic retinopathy: 6-months
follow-up.
Eye.
2009;
23
117-123
- 7
Brown G C, Magargal L E, Schachat A et al.
Neovascular glaucoma. Etiologic considerations.
Ophthalmology.
1984;
91
315-320
- 8
Brown G C, Shah H G, Magargal L E et al.
Central retinal vein obstruction and carotid artery disease.
Ophthalmology.
1984;
91
1627-1633
- 9 Brown G C, Brown M M.
The ocular ischemic syndrome. Joussen AM, Gardner T, Kirchhof B, Ryan SJ Retinal vascular disease. Heidelberg;
Springer 2007: 519-527
- 10
Browning D J, Scott A Q, Peterson C B et al.
The risk of missing angle neovascularization by omitting screening gonioscopy in acute
central retinal vein occlusion.
Ophthalmology.
1998;
105
776-784
- 11 Burton M G Z.
Retinal artery occlusion. Joussen AM, Gardner T, Kirchhof B, Ryan SJ Retinal vascular disease. Heidelberg;
Springer 2007: 507-518
- 12
Caprioli J, Strang S L, Spaeth G L et al.
Cyclocryotherapy in the treatment of advanced glaucoma.
Ophthalmology.
1985;
92
947-954
- 13
Dietlein T S, Hermann M M, Jordan J F.
The medical and surgical treatment of glaucoma.
Dtsch Arztebl Int.
2009;
106
597-605
quiz 606
- 14
Eid T E, Katz L J, Spaeth G L et al.
Tube-shunt surgery versus neodymium:YAG cyclophotocoagulation in the management of
neovascular glaucoma.
Ophthalmology.
1997;
104
1692-1700
- 15
Eid T M, Radwan A, el-Manawy W et al.
Intravitreal bevacizumab and aqueous shunting surgery for neovascular glaucoma: safety
and efficacy.
Can J Ophthalmol.
2009;
44
451-456
- 16
Fakhraie G, Katz L, Prasad A et al.
Surgical outcomes of intravitreal bevacizumab and guarded filtration surgery in neovascular
glaucoma.
Journal of Glaucoma.
2009;
, Epub ahead of print
- 17
Falavarjani K, Modarres M, Nazari H.
Therapeutic effect of bevacizumab injected into the silicone oil in eyes with neovascular
glaucoma after vitrectomy for advanced diabetic retinopathy.
Eye.
2009;
, Epub ahead of print
- 18
Grisanti S, Biester S, Peters S et al.
Intracameral bevacizumab for iris rubeosis.
Am J Ophthalmol.
2006;
142
158-160
- 19
Grover S, Gupta S, Sharma R et al.
Intracameral bevacizumab effectively reduces aqueous vascular endothelial growth factor
concentrations in neovascular glaucoma.
Br J Ophthalmol.
2009;
93
273-274
- 20
Iliev M E, Domig D, Wolf-Schnurrbursch U et al.
Intravitreal bevacizumab (Avastin) in the treatment of neovascular glaucoma.
Am J Ophthalmol.
2006;
142
1054-1056
- 21 Joussen A M, Adamis A P.
Inflammation as a stimulus for vascular leakage and proliferation. Joussen AM, Gardner T, Kirchhof B, Ryan SJ Retinal vascular disease. Heidelberg;
Springer 2007: 97-107
- 22
Katz G J, Higginbotham E J, Lichter P R et al.
Mitomycin C versus 5-fluorouracil in high-risk glaucoma filtering surgery. Extended
follow-up.
Ophthalmology.
1995;
102
1263-1269
- 23
Lang G E.
Laser treatment of diabetic retinopathy.
Dev Ophthalmol.
2007;
39
48-68
- 24
Lim T H, Bae S H, Cho Y J et al.
Concentration of vascular endothelial growth factor after intracameral bevacizumab
injection in eyes with neovascular glaucoma.
Korean J Ophthalmol.
2009;
23
188-192
- 25
Lin S C.
Endoscopic and transscleral cyclophotocoagulation for the treatment of refractory
glaucoma.
J Glaucoma.
2008;
17
238-247
- 26
Madsen P H.
Haemorrhagic glaucoma. Comparative study in diabetic and nondiabetic patients.
Br J Ophthalmol.
1971;
55
444-450
- 27
Mason J O, Albert M A, Mays A et al.
Regression of neovascular iris vessels by intravitreal injection of bevacizumab.
Retina.
2006;
26
839-841
- 28
Matsuyama K, Ogata N, Jo N et al.
Levels of vascular endothelial growth factor and pigment epithelium-derived factor
in eyes before and after intravitreal injection of bevacizumab.
Jpn J Ophthalmol.
2009;
53
243-248
- 29
Mermoud A, Salmon J F, Alexander P et al.
Molteno tube implantation for neovascular glaucoma. Long-term results and factors
influencing the outcome.
Ophthalmology.
1993;
100
897-902
- 30
Mizener J B, Podhajsky P, Hayreh S S.
Ocular ischemic syndrome.
Ophthalmology.
1997;
104
859-864
- 31
Molteno A C, Haddad P J.
The visual outcome in cases of neovascular glaucoma.
Aust N Z J Ophthalmol.
1985;
13
329-335
- 32
Ohnishi Y, Ishibashi T, Sagawa T.
Fluorescein gonioangiography in diabetic neovascularisation.
Graefes Arch Clin Exp Ophthalmol.
1994;
232
199-204
- 33
Ohrt V.
The frequency of rubeosis iridis in diabetic patients.
Acta Ophthalmol (Copenh).
1971;
49
301-307
- 34
Oshima Y, Sakaguchi H, Gomi F et al.
Regression of iris neovascularization after intravitreal injection of bevacizumab
in patients with proliferative diabetic retinopathy.
Am J Ophthalmol.
2006;
142
155-158
- 35 Rüfer F, Roider J.
General concepts in laser treatment for retinal vascular disease. Joussen AM, Gardner T, Kirchhof B, Ryan SJ Retinal vascular disease. Heidelberg;
Springer 2007: 3309-3341
- 36
Saito Y, Higashide T, Takeda H et al.
Beneficial effects of preoperative intravitreal bevacizumab on trabeculectomy outcomes
in neovascular glaucoma.
Acta Ophthalmol.
2009;
, Epub ahead of print
- 37 Schlote T, Bartz-Schmidt K U.
Treatment of rubeotic secondary glaucoma. Joussen AM, Gardner T, Kirchhof B, Ryan SJ Retinal vascular disease. Heidelberg;
Springer 2007: 274-282
- 38
Scott I U, Alexandrakis G, Flynn H W et al.
Combined pars plana vitrectomy and glaucoma drainage implant placement for refractory
glaucoma.
Am J Ophthalmol.
2000;
129
334-341
- 39
Shields M B, Shields S E.
Noncontact transscleral Nd:YAG cyclophotocoagulation: a long-term follow-up of 500
patients.
Trans Am Ophthalmol Soc.
1994;
92
271-287
- 40
Shin J P, Lee J W, Sohn B J, Kim H K et al.
In vivo corneal endothelial safety of intracameral bevacizumab and effect in neovascular
glaucoma combined with ahmed valve implantation.
J Glaucoma.
2009;
18
589-594
- 41
Sidoti P A, Dunphy T R, Baerveldt G et al.
Experience with the Baerveldt glaucoma implant in treating neovascular glaucoma.
Ophthalmology.
1995;
102
1107-1118
- 42
Sivak-Callcott J A, O'Day D M, Gass J D et al.
Evidence-based recommendations for the diagnosis and treatment of neovascular glaucoma.
Ophthalmology.
2001;
108
1767-1776
quiz 1777
1800
- 43
Takihara Y, Inatani M, Fukushima M et al.
Trabeculectomy with mitomycin C for neovascular glaucoma: prognostic factors for surgical
failure.
Am J Ophthalmol.
2009;
147
912-918
- 44
Tsai J C, Feuer W J, Parrish R K et al.
5-Fluorouracil filtering surgery and neovascular glaucoma. Long-term follow-up of
the original pilot study.
Ophthalmology.
1995;
102
887-893
- 45 Tsai J C, Wand M.
Neovascular glaucoma. Albert AM, Miller J Principles and practice of ophthalmology. Philadelphia; Elsevier
2008: 2689-2712
- 46
Uram M.
Ophthalmic laser microendoscope ciliary process ablation in the management of neovascular
glaucoma.
Ophthalmologie.
1992;
99
1823-1828
- 47
Vasudev D, Blair M P, Galasso J et al.
Intravitreal bevacizumab for neovascular glaucoma.
J Ocul Pharmacol Ther.
2009;
25
453-458
- 48
Wakabayashi T, Oshima Y, Sakaguchi H et al.
Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma
secondary to ischemic retinal diseases in 41 consecutive cases.
Ophthalmologie.
2008;
115
1571-1580
- 49
Yazdani S, Hendi K, Pakravan M et al.
Intravitreal bevacizumab for neovascular glaucoma: a randomized controlled trial.
J Glaucoma.
2009;
18
632-637
- 50
Yildirim N, Yalvac I S, Sahin A et al.
A comparative study between diode laser cyclophotocoagulation and the Ahmed glaucoma
valve implant in neovascular glaucoma: a long-term follow-up.
J Glaucoma.
2009;
18
192-196
Priv.-Doz. Dr. med. Randolf A. Widder
Augenklinik St. Martinus-Krankenhaus
Gladbacher Straße 26
40219 Düsseldorf
Email: r.widder@martinus-duesseldorf.de
